Scientists Battle in Court Over Lucrative Patents for Gene-Editing Tool


Robert Underwood, commenting on a court battle over patent rights to a revolutionary gene-editing technology called CRISPR-cas9, said that « part of what makes it such a fun spectator sport is the amount of money that’s at stake. These could potentially be the most valuable biotech patents ever. »